BROADCASTS.com

b'In this episode of S&C\\u2019s Critical Insights, Melissa Sawyer, the Global Head of S&C\\u2019s M&A practice, is joined by the Co-Heads of the Firm\\u2019s Antitrust group, Renata Hesse and Juan Rodriguez, to discuss recent developments surrounding the vertical merger of Illumina and GRAIL, which make DNA sequencing devices and blood-based tests for cancer screening, respectively.\\n\\xa0\\nIn the United States, an administrative law judge recently denied the Federal Trade Commission\\u2019s request to prohibit the transaction on competition grounds. In Europe,\\xa0 the European Commission opened a highly publicized suspensory investigation into the transaction, which is seen as a test case for the EC\\u2019s recently revised policy on reviewing mergers that do not require mandatory reporting to the EC. The partners discuss these developments and how they might impact M&A deals going forward, especially in the pharmaceutical and tech sectors.'